Metabolic Disease clinical trials

Explore recruiting metabolic disease clinical trials.

Recruiting metabolic disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Metabolic Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effect of levothyroxine as adjuvant therapy to a hypocaloric diet in the treatment of obesity: a randomized placebo-controlled trial.

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

BMS CV027-031, A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy

Czechia, Belgium, Norway, Spain, Poland, Hungary +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adolescents (age 12 years to < 18 years) with Symptomatic Obstructive Hypertrophic Cardiomyopathy (SCOUT-HCM)

Germany, Spain, Italy, Ireland, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Control strategies and pharmacogenetic study for the personalized treatment of fatty liver associated with metabolic dysfunction in patients with prediabetes.

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Development and delivery of personalized 3D-printed drugs to improve treatment adherence in children with rare diseases.

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Metabolic Disease trials by city

Metabolic Disease in Toronto Metabolic Disease in Vancouver Metabolic Disease in Montreal Metabolic Disease in Calgary Metabolic Disease in Edmonton Metabolic Disease in Ottawa Metabolic Disease in Winnipeg Metabolic Disease in Quebec City Metabolic Disease in Hamilton Metabolic Disease in Kitchener Metabolic Disease in London Metabolic Disease in Halifax Metabolic Disease in New York Metabolic Disease in Los Angeles Metabolic Disease in Chicago Metabolic Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease